Chicago Partners Investment Group LLC Has $379,000 Stock Holdings in Globe Life Inc. $GL

Chicago Partners Investment Group LLC increased its holdings in Globe Life Inc. (NYSE:GL) by 46.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,033 shares of the company’s stock after purchasing an additional 964 shares during the period. Chicago Partners Investment Group LLC’s holdings in Globe Life were worth $379,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in GL. GAMMA Investing LLC raised its position in Globe Life by 18.8% in the first quarter. GAMMA Investing LLC now owns 5,936 shares of the company’s stock worth $782,000 after purchasing an additional 941 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Globe Life by 8.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 22,799 shares of the company’s stock worth $3,003,000 after purchasing an additional 1,861 shares in the last quarter. State of Alaska Department of Revenue raised its position in Globe Life by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 9,834 shares of the company’s stock worth $1,295,000 after purchasing an additional 260 shares in the last quarter. Blue Trust Inc. raised its position in Globe Life by 42.4% in the first quarter. Blue Trust Inc. now owns 772 shares of the company’s stock worth $102,000 after purchasing an additional 230 shares in the last quarter. Finally, Oppenheimer & Co. Inc. acquired a new position in Globe Life in the first quarter worth about $2,161,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Insider Activity at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 28,952 shares of the stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total value of $4,081,363.44. Following the transaction, the chief financial officer directly owned 30,665 shares in the company, valued at $4,322,845.05. This represents a 48.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael Clay Majors sold 10,000 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the completion of the transaction, the executive vice president owned 47,066 shares in the company, valued at $6,467,339.06. This represents a 17.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,452 shares of company stock worth $7,222,713 over the last ninety days. Company insiders own 1.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Cfra Research raised shares of Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. BMO Capital Markets reaffirmed a “market perform” rating and set a $149.00 price objective (up from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. JPMorgan Chase & Co. upped their price objective on shares of Globe Life from $145.00 to $160.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 8th. Wells Fargo & Company upped their price objective on shares of Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Finally, Truist Financial started coverage on shares of Globe Life in a research note on Tuesday, July 15th. They set a “buy” rating and a $150.00 price objective on the stock. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $152.11.

Globe Life Price Performance

GL opened at $135.54 on Friday. Globe Life Inc. has a one year low of $100.27 and a one year high of $147.83. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. The company’s 50 day simple moving average is $139.57 and its 200-day simple moving average is $129.33. The stock has a market capitalization of $10.98 billion, a P/E ratio of 9.82 and a beta of 0.55.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, beating the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 22.12%. The business had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.52 billion. During the same period in the prior year, the firm earned $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Sell-side analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, October 3rd. Globe Life’s dividend payout ratio is currently 8.63%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.